Remove 2015 Remove FDA Remove Medicare Remove World Health
article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016. Medicare’s National Coverage Determination for Aducanumab – A One-Off or a Pragmatic Path Forward? Reforming the World Health Organization’s Essential Medicines List: Essential but Unaffordable.

FDA 184